Trine Koch

Trine Koch

Auto-generated profile, based on publicly available information

Trine Koch

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2022 in Human Reproduction Update
Verified
Journal Article
Closed access
PDF file
CUCecilie Skaarup Uldbjerg
Cecilie Skaarup Uldbjerg
TKT Koch
T Koch
YLYoun-Hee Lim
Youn-Hee Lim
LGL S Gregersen
L S Gregersen
COC S Olesen
C S Olesen
EBElvira Bräuner
Elvira Bräuner
BACKGROUND: Globally, the ages at pubertal onset for girls and boys have been decreasing during recent decades, partly attributed to excess body fat accumulation. However, a growing body of literature has recognized that endocrine disrupting chemicals (EDCs) may play an important role in this global trend, but the association has not yet been fully established. OBJECTIVE AND RATIONALE: EDCs can interfere with normal hormone function and metabolism and play a role in pubertal onset. We aimed to systematically identify and evaluate the current evidence on the timing of pubertal onset in girls and boys following prenatal or postnatal exposures to xenobiotic EDCs. SEARCH METHODS: Following PRISMA guidelines, we performed a systematic literature search of original peer-reviewed publications in the PubMed database through a block search approach using a combination of index MeSH and free text search terms. Publications were considered if they covered biomarkers of prenatal or postnatal exposures to xenobiotic EDCs (European Commission’s list of category 1 EDCs) measured in maternal or child biospecimen and pubertal onset defined by the progression of the following milestones (and assessed in terms of the following measures): menarche (age), thelarche (Tanner staging) and pubarche (Tanner staging), in girls, and genital stage (Tanner staging), testicular volume (ml) and pubarche (Tanner staging), in boys. OUTCOMES: The literature search resulted in 703 references, of which we identified 52 publications fulfilling the eligibility criteria for the qualitative trend synthesis and 23 publications for the meta-analysis. The qualitative trend synthesis provided data on 103 combinations of associations between prenatal or postnatal exposure to EDC compounds groups and puberty outcomes and the meta-analysis enabled 18 summary risk estimates of meta-associations. WIDER IMPLICATIONS: Statistically significant associations in the qualitative trend synthesis suggested that postnatal exposure to phthalates may be associated with earlier thelarche and later pubarche. However, we did not find consistent evidence in the meta-analysis for associations between timing of pubertal onset in girls and boys and exposures to any of the studied xenobiotic EDCs. We were not able to identify specific pre- or postnatal windows of exposure as particularly critical and susceptible for effects of EDCs. Current evidence is subject to several methodological challenges and inconsistencies and evidence on specific exposure-outcome associations remains too scarce to firmly confirm EDC exposure as a risk factor for changes in age of pubertal onset in the general child population. To create a more uniform foundation for future comparison of evidence and to strengthen pooled studies, we recommend the use of more standardized approaches in the choice of statistical analyses, with exposure transformations, and in the definitions and assessments of puberty outcomes. The impact of mixtures of EDC exposures on the association also remains unestablished and would be valuable to elucidate for prenatal and postnatal windows of exposure. Future large, longitudinal epidemiological studies are needed to clarify the overall association.

16 July 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
EBElvira Bräuner
Elvira Bräuner
YLYoun-Hee Lim
Youn-Hee Lim
TKTrine Koch
Trine Koch
CUCecilie S Uldbjerg
Cecilie S Uldbjerg
LGLaura S Gregersen
Laura S Gregersen
AJAnders Juul
Anders Juul
The incidence of many hormone-dependent diseases, including testicular cancer, has sharply increased in all high-income countries during the 20th century. This is not fully explained by established risk factors. Concurrent, increasing exposure to antiandrogenic environmental endocrine disrupting chemicals (EDCs) in fetal life may partially explain this trend. This systematic review assessed available evidence regarding the association between environmental EDC exposure and risk of testicular cancer (seminomas and nonseminomas). Following PRISMA guidelines, a search of English peer-reviewed literature published prior to December 14, 2020 in the databases PubMed and Embase® was performed. Among the 279 identified records, 19 were eligible for quality assessment and 10 for further meta-analysis. The completeness of reporting was high across papers, but over 50% were considered subject to potential risk of bias. Mean age at diagnosis was 31.9 years. None considered effects of EDC multipollutant mixtures. The meta-analyses showed that maternal exposure to combined EDCs was associated with a higher risk of testicular cancer in male offspring [summary risk ratios: 2.16, (95% CI:1.78-2.62), 1.93 (95% CI:1.49-2.48), and 2.78 (95% CI:2.27-3.41) for all, seminoma, and nonseminoma, respectively]. Similarly, high maternal exposures to grouped organochlorines and organohalogens were associated with higher risk of seminoma and nonseminoma in the offspring. Summary estimates related to postnatal adult male EDC exposures were inconsistent. Maternal, but not postnatal adult male, EDC exposures were consistently associated with a higher risk of testicular cancer, particularly risk of nonseminomas. However, the quality of studies was mixed, and considering the fields complexity, more prospective studies of prenatal EDC multipollutant mixture exposures and testicular cancer are needed.

7 July 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
TKTrine Koch
Trine Koch
EBElvira Bräuner
Elvira Bräuner
ABAlexander S Busch
Alexander S Busch
MHMartha Hickey
Martha Hickey
AJAnders Juul
Anders Juul
Context: Gynecomastia, the proliferation of mammary glandular tissue in the male, is a frequent but little-studied condition. Available prevalence data are based on selected patient populations or autopsy cases with their inherent bias. Objective: The objective of this work is to evaluate the age-related incidence and secular trends in gynecomastia in the general population. Design: An observational, 20-year national registry study was conducted. Setting: This population-based study used nationwide registry data. Participants: Participants included all Danish males (age 0-80 years) with a first-time diagnosis of gynecomastia. Main Outcome Measures: All Danish males (age 0-80 years) were followed up for incident diagnosis of gynecomastia in the Danish National Patient Registry from 1998 to 2017 using the International Codes of Diseases, 10th revision, and the Danish Health Care Classification System. Age-specific incidence rates were estimated. The hypothesis tested in this study was formulated prior to data collection. Results: Overall, a total 17 601 males (age 0-80 years) were registered with an incident diagnosis of gynecomastia within the 20-year study period, corresponding to 880 new cases per year and an average 20-year incidence of 3.4 per 10 000 men (age 0-80 years). The average annual incidence was 6.5/10 000 in postpubertal males age 16 to 20 years and 4.6/10 000 in males age 61 to 80 years, with a respective 5- and 11-fold overall increase in these 2 age groups over the 20-year period. Conclusions: The incidence of gynecomastia has dramatically increased over the last 20 years, implying that the endogenous or exogenous sex-steroid environment has changed, which is associated with other adverse health consequences in men such as an increased risk of prostate cancer, metabolic syndrome, type 2 diabetes, or cardiovascular disorders.

27 August 2021 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
TKTrine Koch
Trine Koch
JJJeanette Therming Jørgensen
Jeanette Therming Jørgensen
JCJane Christensen
Jane Christensen
ADAnne Katrine Duun‐Henriksen
Anne Katrine Duun‐Henriksen
LPLærke Priskorn
Lærke Priskorn
MHMartha Hickey
Martha Hickey

14 October 2025 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
THTrine Koch Hueg
Trine Koch Hueg
YLYoun-Hee Lim
Youn-Hee Lim
SHStine Agergaard Holmboe
Stine Agergaard Holmboe
NMNadia Micali
Nadia Micali
AJAnders Juul
Anders Juul
Context: Early menarche within the general population has previously been linked to increased risk of mental health disorders, and such associations are likely to be even stronger in children diagnosed with extremely early puberty (precocious puberty); however, information is sparse. Objective: Investigate the association between precocious puberty and psychiatric disorders. Design: A large cohort study included individuals in the National Danish Patient Registry with a diagnosis of precocious puberty from January 1, 1995, to December 31, 2020 (n = 9315, 11% boys), comprising patients registered with an ICD-10 diagnosis of central precocious puberty (n = 2955), unspecific premature puberty (n = 3948), premature thelarche (n = 937), and premature adrenarche (n = 1475). All cases were matched with 5 randomly selected referents from the background population (n = 46 566) according to age, sex, and calendar time (at diagnosis). Incident psychiatric disorders were identified in national health registries (average follow-up time of 7.9 years). Results: Precocious puberty (all cases) was associated with a statistically significant increased risk of attention-deficit/hyperactivity disorder (ADHD) (hazard ratio [HR]: 1.58; 95% CI: 1.36-1.84), anxiety (HR: 1.60; 95% CI: 1.48-1.74), autism (HR: 1.94; 95% CI: 1.67-2.25), depression (HR: 1.41; 95% CI: 1.29-1.53), eating disorders (HR: 1.23; 95% CI: 1.03-1.47), and schizophrenia (HR: 1.72; 95% CI: 1.40-2.10) compared to matched referents. Similar results were observed when stratified by sex, but with greatest effect size among boys. The associations were even stronger among individuals with central precocious puberty. Conclusion: Our large register-based cohort study highlights a markedly increased risk of psychiatric disorders among individuals with precocious puberty.

18 December 2020 in Comprehensive Psychoneuroendocrinology
Verified
Journal Article
Open access
EBElvira Bräuner
Elvira Bräuner
TKT. Koch
T. Koch
DDDorota A Doherty
Dorota A Doherty
JDJ.E. Dickinson
J.E. Dickinson
AJA. Juul
A. Juul
MHM. Hickey
M. Hickey
Experimental studies suggest that prenatal stress affects reproductive function in female offspring, but human evidence is sparse and inconsistent. In this present study, we aim to investigate whether maternal psychological stress, quantified as stressful life events during pregnancy, affect reproductive function in the female offspring. In a large population-based pregnancy cohort study (The Raine Study) continuously followed from prenatal life through to adolescence we examined the association between the number of maternal stressful life events in both early and late gestation and subsequent ovarian and uterine function in 228 female adolescent offspring. Mothers prospectively reported stressful life events during pregnancy at 18 and 34 weeks using a standardized 10-point questionnaire. Female offspring (n ​= ​228) age 14–16 years underwent gynecological examination including transabdominal abdominal ultrasound (TAUS) to measure uterine volume and ovarian AFC. Plasma samples on day 2–6 of the spontaneous menstrual cycle measured circulating AMH and inhibin B. Multivariate linear regression analysis was used to examine the associations between maternal stressful life events and reproductive function in female offspring. Adolescents taking hormonal contraception were excluded. Most adolescents (145/228, 64%) were exposed to at least one stressful life event in early gestation and around half (125/228, 55%) were exposed to at least one in later gestation. Exposure to one or more maternal stressful life events in late gestation was associated with a greater uterine volume (β ​= ​0.13, 95% CI 0.04; 0.23) and higher ovarian AFC (β ​= ​0.19, 95% CI 0.02; 0.35) at age 14–16 years. No associations between maternal stressful events in late gestation and reproductive function were identified. No associations between stressful life events in early or late gestation and circulating AMH or Inhibin B were observed. Maternal psychological stress in late, but not early gestation was associated with a significantly greater uterine volume and ovarian antral follicle count (AFC) in adolescent offspring but did not affect ovarian production of antimullerian hormone (AMH) or Inhibin B. These findings suggest that female reproductive function is influenced by prenatal exposure to stress.